-
1دورية أكاديمية
المؤلفون: Jun Liang (251318), Jason R. Zbieg (1892965), Robert A. Blake (8974823), Jae H. Chang (1429789), Stephen Daly (2430460), Antonio G. DiPasquale (1274730), Lori S. Friedman (166879), Thomas Gelzleichter (11113391), Matthew Gill (589302), Jennifer M. Giltnane (11113394), Simon Goodacre (1577413), Jane Guan (166826), Steven J. Hartman (10157036), Ellen Rei Ingalla (8908757), Lorn Kategaya (11113397), James R. Kiefer (1443889), Tracy Kleinheinz (1845637), Sharada S. Labadie (1833826), Tommy Lai (2572615), Jun Li (6494), Jiangpeng Liao (1947631), Zhiguo Liu (594653), Vidhi Mody (8908760), Neville McLean (2128303), Ciara Metcalfe (8908763), Michelle A. Nannini (11113400), Jason Oeh (1845505), Martin G. O’Rourke (11113403), Daniel F. Ortwine (1600621), Yingqing Ran (2100610), Nicholas C. Ray (3064926), Fabien Roussel (3030714), Amy Sambrone (1551289), Deepak Sampath (640340), Leah K. Schutt (11113406), Maia Vinogradova (8908772), John Wai (1503217), Tao Wang (12008), Ingrid E. Wertz (11113409), Jonathan R. White (11113412), Siew Kuen Yeap (1346391), Amy Young (251900), Birong Zhang (1947472), Xiaoping Zheng (566379), Wei Zhou (24328), Yu Zhong (291917), Xiaojing Wang (147040)
مصطلحات موضوعية: Cell Biology, Genetics, Neuroscience, Pharmacology, Biotechnology, Cancer, Infectious Diseases, Chemical Sciences not elsewhere classified, Information Systems not elsewhere classified, Exceptional Preclinical Profile, dose, Bioavailable, human, candidate, combination, liability, Phase, Orally, antagonist, Breast Cancer Breast cancer, wild-type ER α tumor model, GDC -9545, estrogen receptor degrader, antiproliferation, SERD, interaction, Estrogen Receptor Antagonist, giredestrant, Fine-tuning, PDX
-
2دورية أكاديمية
المؤلفون: Peter S. Dragovich (640339), Thomas H. Pillow (3996851), Robert A. Blake (8974823), Jack D. Sadowsky (1984828), Emel Adaligil (2481943), Pragya Adhikari (8433495), Jinhua Chen (1551307), Nicholas Corr (10157033), Josefa dela Cruz-Chuh (4245010), Geoffrey Del Rosario (3996854), Aaron Fullerton (9160761), Steven J. Hartman (10157036), Fan Jiang (144211), Susan Kaufman (491001), Tracy Kleinheinz (1845637), Katherine R. Kozak (1958674), Liling Liu (296450), Ying Lu (66401), Melinda M. Mulvihill (1319328), Jeremy M. Murray (2044333), Aimee O’Donohue (4245019), Rebecca K. Rowntree (9253992), William S. Sawyer (2951898), Leanna R. Staben (1833829), John Wai (1503217), Jian Wang (5901), BinQing Wei (2128288), Wentao Wei (2135263), Zijin Xu (1551310), Hui Yao (240607), Shang-Fan Yu (3342923), Donglu Zhang (2102533), Hongyan Zhang (618068), Shenhua Zhang (10157039), Yongxin Zhao (311082), Hao Zhou (136535), Xiaoyu Zhu (82055)
مصطلحات موضوعية: Biochemistry, Microbiology, Cell Biology, Genetics, Pharmacology, Biotechnology, Immunology, Cancer, Mental Health, Space Science, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, antigen-dependent BRD 4 degradation, Antibody-Mediated Delivery, antiproliferation activities, ubiquitin ligases, Multiple ADCs, chemical literature, Vivo Antitumor Efficacy Heterobifun., antigen-dependent antitumor efficacy, chimeric BRD 4-degrader payloads, BRD 4-degrader antibody conjugates ., Vitro Antiproliferation Activity, tumor models, cell-based experiments, proteolysis-targeting chimeras, PROTAC, BRD 4-targeting chimeric degrader e., mouse xenograft assessments, BRD 4-binding fragment
-
3دورية أكاديمية
المؤلفون: Peter S. Dragovich (640339), Thomas H. Pillow (3996851), Robert A. Blake (8974823), Jack D. Sadowsky (1984828), Emel Adaligil (2481943), Pragya Adhikari (8433495), Jinhua Chen (1551307), Nicholas Corr (10157033), Josefa dela Cruz-Chuh (4245010), Geoffrey Del Rosario (3996854), Aaron Fullerton (9160761), Steven J. Hartman (10157036), Fan Jiang (144211), Susan Kaufman (491001), Tracy Kleinheinz (1845637), Katherine R. Kozak (1958674), Liling Liu (296450), Ying Lu (66401), Melinda M. Mulvihill (1319328), Jeremy M. Murray (2044333), Aimee O’Donohue (4245019), Rebecca K. Rowntree (9253992), William S. Sawyer (2951898), Leanna R. Staben (1833829), John Wai (1503217), Jian Wang (5901), BinQing Wei (2128288), Wentao Wei (2135263), Zijin Xu (1551310), Hui Yao (240607), Shang-Fan Yu (3342923), Donglu Zhang (2102533), Hongyan Zhang (618068), Shenhua Zhang (10157039), Yongxin Zhao (311082), Hao Zhou (136535), Xiaoyu Zhu (82055)
مصطلحات موضوعية: Biochemistry, Microbiology, Cell Biology, Genetics, Pharmacology, Biotechnology, Immunology, Cancer, Mental Health, Space Science, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, antigen-dependent BRD 4 degradation, Antibody-Mediated Delivery, antiproliferation activities, ubiquitin ligases, Multiple ADCs, chemical literature, Vivo Antitumor Efficacy Heterobifun., antigen-dependent antitumor efficacy, chimeric BRD 4-degrader payloads, BRD 4-degrader antibody conjugates ., Vitro Antiproliferation Activity, tumor models, cell-based experiments, proteolysis-targeting chimeras, PROTAC, BRD 4-targeting chimeric degrader e., mouse xenograft assessments, BRD 4-binding fragment
-
4دورية أكاديمية
المؤلفون: Peter S. Dragovich (640339), Thomas H. Pillow (3996851), Robert A. Blake (8974823), Jack D. Sadowsky (1984828), Emel Adaligil (2481943), Pragya Adhikari (8433495), Sunil Bhakta (2951277), Nicole Blaquiere (2117977), Jinhua Chen (1551307), Josefa dela Cruz-Chuh (4245010), Karen E. Gascoigne (3160572), Steven J. Hartman (10157036), Mingtao He (1868638), Susan Kaufman (491001), Tracy Kleinheinz (1845637), Katherine R. Kozak (1958674), Liang Liu (50022), Liling Liu (296450), Qi Liu (33068), Ying Lu (66401), Fanwei Meng (7440827), Melinda M. Mulvihill (1319328), Aimee O’Donohue (4245019), Rebecca K. Rowntree (9253992), Leanna R. Staben (1833829), Steven T. Staben (1845742), John Wai (1503217), Jian Wang (5901), BinQing Wei (2128288), Catherine Wilson (165841), Jianfeng Xin (10157041), Zijin Xu (1551310), Hui Yao (240607), Donglu Zhang (2102533), Hongyan Zhang (618068), Hao Zhou (136535), Xiaoyu Zhu (82055)
مصطلحات موضوعية: Biochemistry, Medicine, Cell Biology, Genetics, Pharmacology, Biotechnology, Immunology, Developmental Biology, Cancer, Space Science, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, entity, Antibody-Mediated Delivery, target proteins, effect intracellular degradation, impact, delivery options, exhibits antigen-dependent antiprol., ubiquitin ligase-mediated ubiquitin., antigen-dependent delivery, vivo pharmacokinetic properties, PC 3-S prostate cancer cells, chimeric entities, Payload Loading, LNCaP prostate cancer cells, novel agents, proteolysis-targeting chimeras, Antibody Linker, intracellular BRD 4 levels
-
5
المؤلفون: Jun Liang (251318), Jason R. Zbieg (1892965), Robert A. Blake (8974823), Jae H. Chang (1429789), Stephen Daly (2430460), Antonio G. DiPasquale (1274730), Lori S. Friedman (166879), Thomas Gelzleichter (11113391), Matthew Gill (589302), Jennifer M. Giltnane (11113394), Simon Goodacre (1577413), Jane Guan (166826), Steven J. Hartman (10157036), Ellen Rei Ingalla (8908757), Lorn Kategaya (11113397), James R. Kiefer (1443889), Tracy Kleinheinz (1845637), Sharada S. Labadie (1833826), Tommy Lai (2572615), Jun Li (6494), Jiangpeng Liao (1947631), Zhiguo Liu (594653), Vidhi Mody (8908760), Neville McLean (2128303), Ciara Metcalfe (8908763), Michelle A. Nannini (11113400), Jason Oeh (1845505), Martin G. O’Rourke (11113403), Daniel F. Ortwine (1600621), Yingqing Ran (2100610), Nicholas C. Ray (3064926), Fabien Roussel (3030714), Amy Sambrone (1551289), Deepak Sampath (640340), Leah K. Schutt (11113406), Maia Vinogradova (8908772), John Wai (1503217), Tao Wang (12008), Ingrid E. Wertz (11113409), Jonathan R. White (11113412), Siew Kuen Yeap (1346391), Amy Young (251900), Birong Zhang (1947472), Xiaoping Zheng (566379), Wei Zhou (24328), Yu Zhong (291917), Xiaojing Wang (147040)
مصطلحات موضوعية: Cell Biology, Genetics, Neuroscience, Pharmacology, Biotechnology, Cancer, Infectious Diseases, Chemical Sciences not elsewhere classified, Information Systems not elsewhere classified, Exceptional Preclinical Profile, dose, Bioavailable, human, candidate, combination, liability, Phase, Orally, antagonist, Breast Cancer Breast cancer, wild-type ER α tumor model, GDC -9545, estrogen receptor degrader, antiproliferation, SERD, interaction, Estrogen Receptor Antagonist, giredestrant, Fine-tuning, PDX
-
6
المؤلفون: Peter S. Dragovich (640339), Thomas H. Pillow (3996851), Robert A. Blake (8974823), Jack D. Sadowsky (1984828), Emel Adaligil (2481943), Pragya Adhikari (8433495), Sunil Bhakta (2951277), Nicole Blaquiere (2117977), Jinhua Chen (1551307), Josefa dela Cruz-Chuh (4245010), Karen E. Gascoigne (3160572), Steven J. Hartman (10157036), Mingtao He (1868638), Susan Kaufman (491001), Tracy Kleinheinz (1845637), Katherine R. Kozak (1958674), Liang Liu (50022), Liling Liu (296450), Qi Liu (33068), Ying Lu (66401), Fanwei Meng (7440827), Melinda M. Mulvihill (1319328), Aimee O’Donohue (4245019), Rebecca K. Rowntree (9253992), Leanna R. Staben (1833829), Steven T. Staben (1845742), John Wai (1503217), Jian Wang (5901), BinQing Wei (2128288), Catherine Wilson (165841), Jianfeng Xin (10157041), Zijin Xu (1551310), Hui Yao (240607), Donglu Zhang (2102533), Hongyan Zhang (618068), Hao Zhou (136535), Xiaoyu Zhu (82055)
مصطلحات موضوعية: Biochemistry, Medicine, Cell Biology, Genetics, Pharmacology, Biotechnology, Immunology, Developmental Biology, Cancer, Space Science, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, entity, Antibody-Mediated Delivery, target proteins, effect intracellular degradation, impact, delivery options, exhibits antigen-dependent antiprol., ubiquitin ligase-mediated ubiquitin., antigen-dependent delivery, vivo pharmacokinetic properties, PC 3-S prostate cancer cells, chimeric entities, Payload Loading, LNCaP prostate cancer cells, novel agents, proteolysis-targeting chimeras, Antibody Linker, intracellular BRD 4 levels
-
7
المؤلفون: Peter S. Dragovich (640339), Thomas H. Pillow (3996851), Robert A. Blake (8974823), Jack D. Sadowsky (1984828), Emel Adaligil (2481943), Pragya Adhikari (8433495), Sunil Bhakta (2951277), Nicole Blaquiere (2117977), Jinhua Chen (1551307), Josefa dela Cruz-Chuh (4245010), Karen E. Gascoigne (3160572), Steven J. Hartman (10157036), Mingtao He (1868638), Susan Kaufman (491001), Tracy Kleinheinz (1845637), Katherine R. Kozak (1958674), Liang Liu (50022), Liling Liu (296450), Qi Liu (33068), Ying Lu (66401), Fanwei Meng (7440827), Melinda M. Mulvihill (1319328), Aimee O’Donohue (4245019), Rebecca K. Rowntree (9253992), Leanna R. Staben (1833829), Steven T. Staben (1845742), John Wai (1503217), Jian Wang (5901), BinQing Wei (2128288), Catherine Wilson (165841), Jianfeng Xin (10157041), Zijin Xu (1551310), Hui Yao (240607), Donglu Zhang (2102533), Hongyan Zhang (618068), Hao Zhou (136535), Xiaoyu Zhu (82055)
مصطلحات موضوعية: Biochemistry, Medicine, Cell Biology, Genetics, Pharmacology, Biotechnology, Immunology, Developmental Biology, Cancer, Space Science, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, entity, Antibody-Mediated Delivery, target proteins, effect intracellular degradation, impact, delivery options, exhibits antigen-dependent antiprol., ubiquitin ligase-mediated ubiquitin., antigen-dependent delivery, vivo pharmacokinetic properties, PC 3-S prostate cancer cells, chimeric entities, Payload Loading, LNCaP prostate cancer cells, novel agents, proteolysis-targeting chimeras, Antibody Linker, intracellular BRD 4 levels
-
8
المؤلفون: Peter S. Dragovich (640339), Thomas H. Pillow (3996851), Robert A. Blake (8974823), Jack D. Sadowsky (1984828), Emel Adaligil (2481943), Pragya Adhikari (8433495), Jinhua Chen (1551307), Nicholas Corr (10157033), Josefa dela Cruz-Chuh (4245010), Geoffrey Del Rosario (3996854), Aaron Fullerton (9160761), Steven J. Hartman (10157036), Fan Jiang (144211), Susan Kaufman (491001), Tracy Kleinheinz (1845637), Katherine R. Kozak (1958674), Liling Liu (296450), Ying Lu (66401), Melinda M. Mulvihill (1319328), Jeremy M. Murray (2044333), Aimee O’Donohue (4245019), Rebecca K. Rowntree (9253992), William S. Sawyer (2951898), Leanna R. Staben (1833829), John Wai (1503217), Jian Wang (5901), BinQing Wei (2128288), Wentao Wei (2135263), Zijin Xu (1551310), Hui Yao (240607), Shang-Fan Yu (3342923), Donglu Zhang (2102533), Hongyan Zhang (618068), Shenhua Zhang (10157039), Yongxin Zhao (311082), Hao Zhou (136535), Xiaoyu Zhu (82055)
مصطلحات موضوعية: Biochemistry, Microbiology, Cell Biology, Genetics, Pharmacology, Biotechnology, Immunology, Cancer, Mental Health, Space Science, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, antigen-dependent BRD 4 degradation, Antibody-Mediated Delivery, antiproliferation activities, ubiquitin ligases, Multiple ADCs, chemical literature, Vivo Antitumor Efficacy Heterobifun., antigen-dependent antitumor efficacy, chimeric BRD 4-degrader payloads, BRD 4-degrader antibody conjugates ., Vitro Antiproliferation Activity, tumor models, cell-based experiments, proteolysis-targeting chimeras, PROTAC, BRD 4-targeting chimeric degrader e., mouse xenograft assessments, BRD 4-binding fragment
-
9
المؤلفون: Peter S. Dragovich (640339), Thomas H. Pillow (3996851), Robert A. Blake (8974823), Jack D. Sadowsky (1984828), Emel Adaligil (2481943), Pragya Adhikari (8433495), Jinhua Chen (1551307), Nicholas Corr (10157033), Josefa dela Cruz-Chuh (4245010), Geoffrey Del Rosario (3996854), Aaron Fullerton (9160761), Steven J. Hartman (10157036), Fan Jiang (144211), Susan Kaufman (491001), Tracy Kleinheinz (1845637), Katherine R. Kozak (1958674), Liling Liu (296450), Ying Lu (66401), Melinda M. Mulvihill (1319328), Jeremy M. Murray (2044333), Aimee O’Donohue (4245019), Rebecca K. Rowntree (9253992), William S. Sawyer (2951898), Leanna R. Staben (1833829), John Wai (1503217), Jian Wang (5901), BinQing Wei (2128288), Wentao Wei (2135263), Zijin Xu (1551310), Hui Yao (240607), Shang-Fan Yu (3342923), Donglu Zhang (2102533), Hongyan Zhang (618068), Shenhua Zhang (10157039), Yongxin Zhao (311082), Hao Zhou (136535), Xiaoyu Zhu (82055)
مصطلحات موضوعية: Biochemistry, Microbiology, Cell Biology, Genetics, Pharmacology, Biotechnology, Immunology, Cancer, Mental Health, Space Science, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, antigen-dependent BRD 4 degradation, Antibody-Mediated Delivery, antiproliferation activities, ubiquitin ligases, Multiple ADCs, chemical literature, Vivo Antitumor Efficacy Heterobifun., antigen-dependent antitumor efficacy, chimeric BRD 4-degrader payloads, BRD 4-degrader antibody conjugates ., Vitro Antiproliferation Activity, tumor models, cell-based experiments, proteolysis-targeting chimeras, PROTAC, BRD 4-targeting chimeric degrader e., mouse xenograft assessments, BRD 4-binding fragment